Introduction: Clinical studies have suggested anti-tumor efficacy of somatostatin analog (SSA) in the treatment of neuroendocrine tumors (NETs).
Aim(s): We investigated the prognostic significance of expression of somatostatin receptors (SSTRs) in patients with NETs generally, and in a subset of patients treated with SSA.
Materials and methods: We evaluated immunohistochemical expression of SSTR1, 2, 3 and 5 in a cohort of archival NETs. We correlated expression levels with clinical outcomes after adjusting for other clinical prognostic variables.
Conference: 11th Annual ENETS Conference 2014 (2014)
Category: Epidemiology/Natural history/Prognosis - Prognosis
Presenting Author: Dr Tingting Li
, Qian Z
, Ter-Minassian M
, Chan J A
, Brais L K
, Brooks N
, Lin X
, Christiani D C
, Fuchs C S
, Ogino S
, Kulke M H
To read results and conclusion, please login ...
Further abstracts you may be interested in